COUGH

This completed study looked at how two different Robitussin cough syrup regimens affect quality of life in 244 adults with coughs from the common cold. One group used a single daytime/nighttime syrup, while the other used separate daytime and nighttime syrups. Researchers measure…

This study tested whether Reconyl, a mix of four Indonesian herbs, can safely ease acute cough better than a placebo. 144 adults with sudden cough took either Reconyl or a placebo three times daily for 7 days. Researchers measured changes in cough severity and quality of life, al…

This study tested a drug called orvepitant to see if it can reduce chronic coughing in people with idiopathic pulmonary fibrosis (IPF), a serious lung disease. About 80 adults with IPF and persistent cough took either orvepitant or a placebo in two separate periods, and researche…

This study tested whether numbing the nerve that controls the voice box could reduce chronic cough. 17 adults with a suspected overactive cough reflex received either four nerve blocks or four placebo injections. Researchers tracked cough severity and quality of life using questi…

This study tested a special type of radiofrequency (448 kHz) combined with manual techniques to help people with ongoing breathing issues after COVID-19. 96 adults who had COVID and still had cough, shortness of breath, or fatigue for over a month received the treatment. The goal…

This study tested whether three simple measurements—blood eosinophils, FeNO (a breath test), and total IgE—can predict how well patients with chronic cough respond to inhaled corticosteroids. Over 500 adults with a cough lasting 8 weeks or more participated. The goal was to help …

This study looked at how camlipixant, an experimental drug for chronic cough, behaves in people with liver problems compared to healthy volunteers. 32 adults aged 18-75 took part to see if liver impairment changes drug levels or safety. The goal is to help doctors decide the righ…

This study tested a smartphone app called Hyfe Cough Tracker to see if it can accurately count coughs in people with lung conditions like COPD, asthma, or COVID-19. Researchers compared the app's cough counts to patients' own reports and expert listening. The goal was to improve …